Literature DB >> 4000633

In vitro evaluation of cellular inhibitory potential of various antineoplastic drugs and dexamethasone.

R Fiscella, G A Peyman, J Elvart, B Yue.   

Abstract

We evaluated the in vitro cellular inhibitory rates of eight antineoplastic agents and dexamethasone for rabbit retinal pigment epithelial cells and rabbit corneal fibroblasts. Doxorubicin was the most effective chemotherapeutic agent to inhibit cellular proliferation (-90%). Compared to the controls, the percentage variation in cell number for single agents ranged from +26% to -90%. Chemotherapy drugs in combination also were evaluated and found to be not superior to the single agents. Cellular inhibitory rates for combination agents ranged from -34% to -72%. Dexamethasone in the concentrations used did not significantly inhibit or stimulate cellular proliferation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4000633

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  4 in total

1.  Clearance of microsphere-entrapped 5-fluorouracil and cytosine arabinoside from the vitreous of primates.

Authors:  G A Peyman; M Conway; B Khoobehi; K Soike
Journal:  Int Ophthalmol       Date:  1992-03       Impact factor: 2.031

2.  Toxicity of 1-(beta-D-arabinofuranosyl)cytosine after intravitreal injection in the rabbit eye.

Authors:  J J Diets-Ouwehand; R J de Keizer; G F Vrensen; S Groen-Jansen; J A van Best
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

3.  Evaluation of toxicity and efficacy of a combination of antineoplastic agents in the prevention of PVR.

Authors:  M Salah-Eldin; G A Peyman; M el-Aswad; B Bandok; M M Bahgat; M R Niesman
Journal:  Int Ophthalmol       Date:  1994       Impact factor: 2.031

4.  In vitro vitamin K3 effect on conjunctival fibroblast migration and proliferation.

Authors:  I Pinilla; L B Izaguirre; F J Gonzalvo; E Piazuelo; M A Garcia-Gonzalez; A I Sanchez-Cano; F Sopeña
Journal:  ScientificWorldJournal       Date:  2014-01-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.